Prime Capital Investment Advisors LLC Purchases New Stake in Trulieve Cannabis Corp. $TRLV

Prime Capital Investment Advisors LLC acquired a new position in shares of Trulieve Cannabis Corp. (NYSE:TRLV) during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm acquired 70,670 shares of the company’s stock, valued at approximately $770,000.

Wall Street Analysts Forecast Growth

TRLV has been the topic of a number of recent research reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Trulieve Cannabis in a research report on Friday, September 11th. Wall Street Zen cut Trulieve Cannabis from a “buy” rating to a “hold” rating in a research report on Saturday, August 8th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $15.00 price target on shares of Trulieve Cannabis in a research note on Friday. One equities research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $15.00.

Trulieve Cannabis Stock Down 4.8%

NYSE:TRLV opened at $10.40 on Friday. Trulieve Cannabis Corp. has a 52 week low of $4.62 and a 52 week high of $13.28. The stock’s fifty day moving average price is $11.17. The firm has a market capitalization of $2.00 billion and a PE ratio of 94.52. The company has a quick ratio of 3.98, a current ratio of 5.94 and a debt-to-equity ratio of 0.45.

Trulieve Cannabis (NYSE:TRLV) last issued its quarterly earnings data on Friday, August 7th. The company reported $0.11 earnings per share for the quarter, beating analysts’ consensus estimates of $0.06 by $0.05. The business had revenue of $271.00 million during the quarter, compared to analysts’ expectations of $268.82 million. Trulieve Cannabis had a negative return on equity of 4.24% and a negative net margin of 41.55%. On average, sell-side analysts expect that Trulieve Cannabis Corp. will post 0.31 EPS for the current fiscal year.

Trulieve Cannabis Company Profile

Trulieve Cannabis Corp. is a vertically integrated cannabis company that cultivates, processes and sells medical and adult-use cannabis products. Its offerings include flower, pre-rolls, concentrates, vaporizers, edibles, tinctures, capsules and topical products, sold through retail dispensaries and other approved channels under brands such as Trulieve, Cultivar Collection, Muse, Roll One and Alchemy.

Founded in 2015, Trulieve initially built its business around Florida’s medical cannabis market and later expanded into additional U.S.